These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24668504)

  • 1. Brain metastases associated with germ cell tumors may be treated with chemotherapy alone.
    Hardt A; Krell J; Wilson PD; Harding V; Chowdhury S; Mazhar D; Berney D; Stebbing J; Shamash J
    Cancer; 2014 Jun; 120(11):1639-46. PubMed ID: 24668504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy.
    Shamash J; Mee M; Sarker SJ; Wilson P; Ansell W; Greenwood M; Berney D; Alifrangis C
    BJU Int; 2020 Jun; 125(6):843-852. PubMed ID: 31688976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH
    Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
    Kollmannsberger C; Nichols C; Bamberg M; Hartmann JT; Schleucher N; Beyer J; Schöfski P; Derigs G; Rüther U; Böhlke I; Schmoll HJ; Kanz L; Bokemeyer C
    Ann Oncol; 2000 May; 11(5):553-9. PubMed ID: 10907948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain metastases in patients with testicular cancer.
    Bokemeyer C; Nowak P; Haupt A; Metzner B; Köhne H; Hartmann JT; Kanz L; Schmoll HJ
    J Clin Oncol; 1997 Apr; 15(4):1449-54. PubMed ID: 9193339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases in children and adolescents with extracranial germ cell tumor - data of the MAHO/MAKEI-registry.
    Göbel U; Schneider DT; Teske C; Schönberger S; Calaminus G
    Klin Padiatr; 2010 May; 222(3):140-4. PubMed ID: 20514616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of brain metastases from germ cell tumors: a single center experience.
    Boyle HJ; Jouanneau E; Droz JP; Fléchon A
    Oncology; 2013; 85(1):21-6. PubMed ID: 23816811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
    Shamash J; Powles T; Ansell W; Berney D; Stebbing J; Mutsvangwa K; Wilson P; Asterling S; Liu S; Wyatt P; Joel SP; Oliver RT
    Br J Cancer; 2007 Aug; 97(3):308-14. PubMed ID: 17609665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome of patients with brain metastases from malignant germ cell tumors.
    Fosså SD; Bokemeyer C; Gerl A; Culine S; Jones WG; Mead GM; Germa-Luch JR; Pont J; Schmoll HJ; Tjulandin S
    Cancer; 1999 Feb; 85(4):988-97. PubMed ID: 10091779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases.
    Doyle DM; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1361-4. PubMed ID: 18374223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metastases and testicular tumors: long-term survival.
    Spears WT; Morphis JG; Lester SG; Williams SD; Einhorn LH
    Int J Radiat Oncol Biol Phys; 1992; 22(1):17-22. PubMed ID: 1370066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases.
    Casey DL; Pitter KL; Imber BS; Lin A; Chan TA; Beal K; Yamada Y; Feldman DR; Yang TJ
    J Neurooncol; 2019 May; 142(3):523-528. PubMed ID: 30771201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base.
    Girones R; Aparicio J; Roure P; Germa-Lluch JR; García Del Muro X; Vazquez-Estevez S; Saenz A; Sastre J; Arranz Arija J; Gallardo E; Gonzalez-Billalabeitia E; Sanchez-Hernandez A; Terrasa J; Hernandez A; Santander C; Cillan E; Sagastibelza N; Almenar-Cubells D; Lopez Brea M; Maroto JP;
    Clin Transl Oncol; 2014 Nov; 16(11):959-65. PubMed ID: 24719184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment.
    Salvati M; Piccirilli M; Raco A; Santoro A; Frati R; Lenzi J; Lanzetta G; Agrillo A; Frati A
    Neurosurg Rev; 2006 Apr; 29(2):130-7. PubMed ID: 16328533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
    Rodenhuis S; de Wit R; de Mulder PH; Keizer HJ; Sleijfer DT; Lalisang RI; Bakker PJ; Mandjes I; Kooi M; de Vries EG
    Ann Oncol; 1999 Dec; 10(12):1467-73. PubMed ID: 10643538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival after brain metastases in non-seminomatous germ cell tumours with combined modality treatment.
    Raghavan D; Mackintosh JF; Fox RM; Rogers J; Duval P; Besser M
    Br J Urol; 1987 Oct; 60(4):364-7. PubMed ID: 2825897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of brain metastasis in nonseminomatous germ cell tumours.
    Mahalati K; Bilen CY; Ozen H; Aki FT; Kendi S
    BJU Int; 1999 Mar; 83(4):457-61. PubMed ID: 10210571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
    Loriot Y; Pagliaro L; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Laplanche A; Le Teuff G; Culine S; Fizazi K
    Eur J Cancer; 2017 Dec; 87():140-146. PubMed ID: 29149760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.